By David Tuller, DrPH I am slowly getting back to my efforts to highlight Mahana Therapeutics’ continuing misrepresentation of its new web-based cognitive behavior therapy program for irritable bowel syndrome. In January, the start-up company that it had licensed the program from King’s College London, based on a high-profile study published last year in Gut, …
Trial By Error: My Letter to IBS Study’s Corresponding Author Read More »
By David Tuller, DrPH Last year, Archives of Disease in Childhood slapped a 3000-word correction on a University of Bristol study of the Lightning Process. The lead investigator was Bristol’s ethically and methodologically challenged pediatrician, Professor Esther Crawley, who failed to disclose to the journal that the study had violated core scientific principles.
By David Tuller, DrPH A few weeks ago, the Oxford Health NHS Foundation Trust posted a pamphlet about coronavirus and fatigue that could have been written by the GET/CBT ideological brigades in the 1990s. It was attributed to–or blamed on?–a mysterious entity called the “psychosocial response group.” No information about these psychosocialists was available on …
Trial By Error: Oxford Health’s Response to My Freedom of Information Request Read More »
By David Tuller, DrPH One of Mahana Therapeutics’ business advisers is Dr Harpreet Sood, identified as the National Health Service’s associate chief clinical information officer. (Actually, Mahana seems to have it wrong; it looks like Dr Sood is still be at the NHS but moved on a while ago to another position. I guess accuracy …
Trial By Error: A Letter to Mahana’s NHS-Linked Business Adviser Read More »
By David Tuller, DrPH Back in February, I wrote to some science advisers to Mahana Therapeutics to alert them to the company’s unjustified claims about the impact of its web-based program on the symptoms of irritable bowel syndrome. Two of them–Dr Peter Lu and Dr Carlo di Lorenzo–are gastroenterology specialists at Nationwide Children’s Hospital in …
Trial By Error: Another Nudge to Mahana’s Gasteroenterology Advisers Read More »
If you appreciate this piece and/or my work in general, here’s a link to my current UC Berkeley crowdfunding effort: https://crowdfund.berkeley.edu/project/20159 ********** By David Tuller, DrPH Today I sent a third letter to Dr Mel Heyman, a prominent gastroenterologist at the University of California, San Francisco. Dr Heyman is one of Mahana Therapeutics’ science advisers. I’ve …
